ArticleBioinformation2026
Cytomorphological spectrum of thyroid lesions using the Bethesda system: A retrospective study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fine Needle Aspiration Cytology (FNAC) is a reliable, minimally invasive technique for evaluating thyroid lesions and the Bethesda System standardizes cytological reporting and clinical decision-making. This retrospective study analyzed 105 patients with palpable thyroid swellings over 1.5 years, classifying lesions according to the Bethesda System (Categories I-VI). The majority of patients were females (86%) with peak incidence in the 31-40 years age group. Most cases were benign (Category II), accounting for 88.5%, while 11.5% were categorized as follicular neoplasm or suspicious for malignancy, indicating higher malignancy risk. Thus, data shows the effectiveness of FNAC combined with the Bethesda system in ensuring accurate diagnosis, risk stratification and appropriate management of thyroid lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.